YA-101 Receives Bronze Award (Pharmaceutical Category) at the 2026 National Pharmaceutical Technology & Research Development Award
YA-101, our flagship drug for Multiple System Atrophy (MSA), has received the Bronze Award in the Pharmaceutical Category of the 2026 National Pharmaceutical Technology & Research Development Award, presented by the Taiwan Food and Drug Administration (TFDA), Ministry of Health and Welfare.